Marshall Wace, LLP Repare Therapeutics Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 119,108 shares of RPTX stock, worth $190,572. This represents 0.0% of its overall portfolio holdings.
Number of Shares
119,108
Previous 82,590
44.22%
Holding current value
$190,572
Previous $272,000
50.37%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RPTX
# of Institutions
62Shares Held
35.4MCall Options Held
50KPut Options Held
300-
Bvf Inc San Francisco, CA10.3MShares$16.5 Million1.13% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$5.4 Million3.82% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$5.32 Million0.27% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.75 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$4.23 Million23.86% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $67.1M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...